Hello

I am new to CRISPR-Cas9 and, for my project, I started to collaborate with another lab that claims expertise on this technique. The objective is to produce 3 cell lines, each with a knockout for a different gene. They did all the process of cloning the plasmid until viral transfection, where a point mutation was induced and an antibiotic resistence gene was added and then selected for.

From what I understand, all cells they gave me are resistant to antibiotic but not all cells necessarily have the mutation or the same mutation, and the solution for that, as far as I know, would be single cloning. However, they said single cloning would not be necessary and that all I had to do was run a western blot for the targets in this heterogeneous cell pool to be sure the knockouts worked. They said if the band was weaker or had a different size it would prove it worked. They also said I could already run phenotypic experiments and it would show it worked as well, but, according to them, the definitive proof is the western blot.

Because I am completely new to this, I just wanted to know if such decisions make sense. I just find it a bit weird because I would have to do single cloning anyway in the end. It wouldnt make sense to me to ever try to check the phenotype of a heterogenous cell pool, if I don't even know the mutation rate of the cells, and I assume such rates might even change every time I plate those cells. Moreover, I think that there might be the possibility the protein could maintain the same size even if it became dysfunctional with the knockout.

I found those decisions weird, but I don't have enough experience with the technique to have a solid opinion. Any thoughts?

More Diogo Moraes's questions See All
Similar questions and discussions